A cohort study evaluating the efficacy and safety of vedolizumab for patients, refractory to anti-TNF-α treatment in inflammatory bowel disease

Al-Madhi, Sara

Inflammatory bowel disease (IBD) is a chronic illness and is considered as one of the most challenging gastrointestinal diseases to manage. IBD involves both Crohn’s disease (CD) and ulcerative colitis (UC). The disease manifests by bouts of relapse and remission. Management approaches introduced ov